Search results
Vertex Pharmaceuticals (VRTX) – Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 23 hours ago5/27/2024 – Vertex Pharmaceuticals was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating. 5/19/2024 – Vertex Pharmaceuticals ...
Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Pr
Guru Focus· 16 hours agoVertex Pharmaceuticals Inc (VRTX, Financial) recently noted a daily loss of 2.23%, yet it maintains a 3-month gain of 4.7%. This article delves into the valuation analysis ...
Vertex Pharmaceuticals, Inc. (VRTX) gets rating Upgrade from Evercore ISI – Knox Daily
Knox Daily· 1 day agoVertex Pharmaceuticals, Inc.’s recently made public that its Director SACHS BRUCE I unloaded Company’s shares for reported $3.17 million on May 22 ’24. In the deal valued ...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 3 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
NEXCOM, CTOne, and Vertex Join Forces to Enhance Private Network Security
Morning Times· 1 day agoNEXCOM, a leading supplier of network solutions, CTOne, a global cybersecurity leader in...
Vertex CEO Kewalramani sells over $6.7 million in company stock By Investing.com
Investing.com· 6 days agoVertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX) CEO and President Reshma Kewalramani...
New Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
Investor's Business Daily· 4 days agoCystic fibrosis treatment leader Vertex Pharmaceuticals scored a breakout from a cup base the past...
Insider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 4 days agoOn May 22, 2024, Bruce Sachs, Director at Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 4 days agoRegardless of what happens, investing in market leaders with robust underlying businesses and excellent prospects is still usually a good idea. Let's...
Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
GuruFocus.com via Yahoo Finance· 6 days agoOn May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX),...